Lam Research Other Income (Expense) decreased by 234.3% to -$35.46M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 41.6%, from -$25.04M to -$35.46M. Over 3 years (FY 2021 to FY 2025), Other Income (Expense) shows an upward trend with a -19.9% CAGR.
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
other_income_expense_net| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$7.17M | -$28.86M | $18.00M | -$57.40M | -$120.45M | -$43.10M | -$28.23M | -$3.33M | $2.60M | $29.84M | $36.07M | $27.80M | $30.08M | $14.26M | -$25.04M | $37.85M | $30.07M | $26.41M | -$35.46M |
| QoQ Change | — | -302.7% | +162.4% | -418.9% | -109.8% | +64.2% | +34.5% | +88.2% | +178.1% | >999% | +20.9% | -22.9% | +8.2% | -52.6% | -275.5% | +251.2% | -20.6% | -12.2% | -234.3% |
| YoY Change | — | — | — | — | <-999% | -49.3% | -256.9% | +94.2% | +106.0% | +205.7% | >999% | — | >999% | -52.2% | -169.4% | +36.2% | -0.0% | +85.2% | -41.6% |